Albany, New York 12208


The purpose of the study is to learn if monitoring dialysis access blood flow during dialysis treatment with a transonic machine (an ultrasound technique) will prevent (or reduce) the development of dialysis access thrombosis (clotting). Investigators would like to study if monitoring with a specific technique called ultrasound dilution technique can help prevent problems with access when compared to what is the current standard of care for patients.


Inclusion Criteria: - Chronic hemodialysis patients undergoing dialysis therapy via an upper extremity arteriovenous access (arteriovenous fistula or an arteriovenous graft) will be enrolled to have monthly surveillance flow measurement using Transonic system or physical examination of the arteriovenous access by qualified person at least once a month for a period of 2 years. Exclusion Criteria: - Patients requiring surgical intervention on the arteriovenous access. - History of access thrombosis (one or more access thrombosis of the current arteriovenous access). - Patients with signs of access infection. - Patients with a malignancy. - Patients with life expectancy of less than six months. - Unable to understand the study. - Unable to sign the consent form. - Patients with psychiatric disorder. - Age less than 18 or greater than 80 years. - Adults unable to consent - Individuals who are not yet adults (infants, children, teenagers) - Pregnant women - Prisoners



Primary Contact:

Principal Investigator
Loay Salman, MD
University of Miami

Ivy Machado, RN
Phone: 786-473-0802

Backup Contact:


Location Contact:

Albany, New York 12208
United States

Nicolle Bateman
Phone: 518-456-2429

Site Status: Recruiting

Data Source:

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.